These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 17951266
1. Symptom improvement in postural orthostatic tachycardia syndrome with the sinus node blocker ivabradine. Ewan V, Norton M, Newton JL. Europace; 2007 Dec; 9(12):1202. PubMed ID: 17951266 [No Abstract] [Full Text] [Related]
2. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine. Mehta N, Bapat A, Tedrow U, Stevenson WG, Koplan B. Europace; 2017 Jul 01; 19(7):1100. PubMed ID: 28431002 [No Abstract] [Full Text] [Related]
3. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP. J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555 [Abstract] [Full Text] [Related]
4. Treatment of inappropriate sinus tachycardia with ivabradine in a patient with postural orthostatic tachycardia syndrome and a dual chamber pacemaker. Khan S, Hamid S, Rinaldi C. Pacing Clin Electrophysiol; 2009 Jan 09; 32(1):131-3. PubMed ID: 19140923 [Abstract] [Full Text] [Related]
5. Ivabradine as an alternative therapeutic trial in the therapy of inappropriate sinus tachycardia: a case report. Schulze V, Steiner S, Hennersdorf M, Strauer BE. Cardiology; 2008 Jan 09; 110(3):206-8. PubMed ID: 18057886 [Abstract] [Full Text] [Related]
6. Highlights in clinical autonomic neurosciences: treatment insights for postural tachycardia syndrome and inappropriate sinus tachycardia. Raj SR. Auton Neurosci; 2013 Oct 09; 177(2):72-3. PubMed ID: 23830785 [No Abstract] [Full Text] [Related]
7. Ivabradine in patients with inappropriate sinus tachycardia. Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, Kääb S. Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec 09; 382(5-6):483-6. PubMed ID: 20859616 [Abstract] [Full Text] [Related]
8. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction. Sette A, Martino A, Lioy E, Calò L. J Cardiovasc Electrophysiol; 2010 Jul 09; 21(7):815-7. PubMed ID: 20233274 [Abstract] [Full Text] [Related]
9. Ivabradine: a ray of hope for inappropriate sinus tachycardia. Scheinman MM, Vedantham V. J Am Coll Cardiol; 2012 Oct 09; 60(15):1330-2. PubMed ID: 22981552 [No Abstract] [Full Text] [Related]
10. Single centre experience of ivabradine in postural orthostatic tachycardia syndrome. McDonald C, Frith J, Newton JL. Europace; 2011 Mar 09; 13(3):427-30. PubMed ID: 21062792 [Abstract] [Full Text] [Related]
11. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope. Sutton R, Salukhe TV, Franzen-McManus AC, Collins A, Lim PB, Francis DP. Europace; 2014 Feb 09; 16(2):284-8. PubMed ID: 24072450 [Abstract] [Full Text] [Related]
12. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity. Nwazue VC, Paranjape SY, Black BK, Biaggioni I, Diedrich A, Dupont WD, Robertson D, Raj SR. J Am Heart Assoc; 2014 Apr 10; 3(2):e000700. PubMed ID: 24721800 [Abstract] [Full Text] [Related]
13. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Kaplinsky E, Comes FP, Urondo LS, Ayma FP. Cardiol J; 2010 Apr 10; 17(2):166-71. PubMed ID: 20544616 [Abstract] [Full Text] [Related]
14. Sinus tachyarrhythmias and the specific bradycardic agents: a marriage made in heaven? Yusuf S, Camm AJ. J Cardiovasc Pharmacol Ther; 2003 Jun 10; 8(2):89-105. PubMed ID: 12808482 [Abstract] [Full Text] [Related]
15. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients. Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ. Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784 [Abstract] [Full Text] [Related]
16. [Postural tachycardia syndrome]. Makai A, Tahin T, Simor T, Csanádi Z, Rudas L. Orv Hetil; 2005 Mar 13; 146(11):515-20. PubMed ID: 15813190 [Abstract] [Full Text] [Related]
17. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies. Mathew ST, Po SS, Thadani U. Heart Rhythm; 2018 Feb 13; 15(2):240-247. PubMed ID: 29017929 [Abstract] [Full Text] [Related]